The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

PDF) Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

Pan- and isoform-specific inhibition of Hsp90: Design strategy and

HSP90 inhibitors induce GPNMB cell-surface expression by

β-Escin overcomes trastuzumab resistance in HER2-positive breast

NCT-58, HSP90 C-terminal Inhibitor

Design, synthesis, and biological evalution of bifunctional

Design, synthesis, and biological evalution of bifunctional

Design, synthesis, and biological evalution of bifunctional

PDF) In Silico Discovery and Optimisation of a Novel Structural

Following the design path of isoform-selective Hsp90 inhibitors

Generation and characterization of cellular models expressing

Soeun Park's research works Korea University, Seoul (KU) and

Biomolecules, Free Full-Text

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab